ArticleInflammopharmacology2026
Multimodal therapeutic potential of Reinwardtia indica Dumort. in rodent model of cerebral ischemia: Attenuations of oxidative and neuroinflammatory stress, restoration of neurotransmitter and mitochondrial homeostasis, suppression of apoptotic signaling and preservation of blood-brain barrier integrity.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke is a major cause of death and long-term neurological disability, driven by complex mechanisms including excitotoxicity, oxidative stress, neuroinflammation, mitochondrial dysfunction, blood–brain barrier (BBB) disruption, and neuronal apoptosis. The limited efficacy of current therapies necessitates the development of multi-target neuroprotective strategies. Reinwardtia indica Dumort., a traditional medicinal plant rich in bioactive phytoconstituents, represents a promising candidate. Thus, the present study aimed to elucidate the neuroprotective potential of R. indica hydroalcoholic extract against cerebral ischemia–reperfusion injury in rats and elucidated its underlying multi-target mechanisms. Cerebral ischemia was induced in Wistar rats via middle cerebral artery occlusion (MCAo), and rats received extract (250 and 500 mg/kg, p.o.) for seven days post-ischemia. Neurological, behavioural, biochemical, and histopathological assessments were performed on day 1 and day 7 post-ischemia, including evaluation of oxidative stress, inflammatory cytokines, mitochondrial enzyme activities, neurotransmitter levels, apoptotic markers, BBB integrity, and infarct size. R. indica significantly reduced infarct volume and improved neuronal survival. Treatment attenuated oxidative and neuroinflammatory stress, restored endogenous antioxidant defenses, suppressed apoptotic signaling, and preserved mitochondrial integrity through normalization of electron transport chain complex activities. Neurotransmitter homeostasis and BBB integrity were also markedly restored. Furthermore, these molecular effects translated into significant improvements in motor, sensorimotor, and cognitive performance. R. indica exerts sustained, multi-target neuroprotection, highlighting its potential as a promising plant-based therapeutic for the management of ischemic stroke. However, for clinical translation, more focus should be given on validating mechanisms and conducting comprehensive pharmacokinetic and safety assessments.
Indexed as
Identifiers
41910702What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.